Stugeron

Stugeron is a medicinal product that belongs to the group of calcium channel blockers with the primary effect on the vessels of the brain.

In other words, it can be said that Stugeron is a vasodilator that improves blood circulation in the brain, as well as peripheral organs. The drug effectively normalizes cerebral circulation and eliminates symptoms in hypertension with encephalopathy, with atherosclerosis cerebral vessels, dementia of vascular origin, post-stroke period, after traumatic brain injury, etc.

Stugeron is effective in treating the following disorders of peripheral circulation: trophic ulcers, numbness in the extremities, diabetic angiopathy, endarteritis, etc.

Clinical and pharmacological group

The calcium channel blocker with a predominant effect on the vessels of the brain.

Terms of sale from pharmacies

Can buyby prescription.

Price

How much does Stugeron cost in pharmacies? The average price is at the level of240 rubles.

Composition and form of release

The medicinal form of Stugeron - tablets: round, flat, white or almost white, with a facet, with a risk fault on one side and engraving "STUGERON" - on the other, practically odorless (25 pcs. in blisters, 2 blisters in a cardboard bundle).

instagram viewer

  • Active ingredient: cinnarizine - 25 mg in 1 tablet.

Auxiliary components: potato starch, corn starch, povidone, colloidal silicon dioxide, lactose monohydrate, magnesium stearate, talc.

pharmachologic effect

The active ingredient of the drug is cinnarizine. It has a blocking effect on the calcium channels, thereby reducing the flow of calcium into the cell. This leads to a decrease in the tone of the walls of the blood vessels, which in turn ensures their relaxation and increased lumen of the vessels. Thus, blood circulation in the tissues improves, as well as their nutrition and oxygen saturation.

The most pronounced action of Stugeron is manifested on the vessels of the brain and peripheral tissues. This reduces intracranial pressure and improves blood microcirculation.

It is important to understand that the action of the drug is tissue-selective and it does not affect blood pressure, so it is pointless to try with it to treat hypertension. There is also no change in heart rate.

Pharmacokinetics

After application, the drug is absorbed within an hour. However, its bioavailability directly depends on the content of hydrochloric acid in the stomach.

The maximum concentration in the blood is noted 1-3 hours after the application, and the half-life of the drug is 4 hours.

Metabolic processes occur in the liver by glucuronation. The products of the metabolism of the drug substance are excreted from the body by 1/3 of the kidneys and 2/3 of the intestines.

Indications for use

Treatment:

  • Symptoms of cerebrovascular origin (headache of vascular genesis, tinnitus, dizziness, irritability);
  • Vestibular disorders (including tinnitus, dizziness, nystagmus, Meniere's disease, nausea and vomiting of labyrinthine origin);
  • Violations of peripheral circulation (thrombophlebitis, Raynaud's disease, intermittent claudication, diabetic angiopathy, trophic disorders, including varicose and trophic ulcers).

Prevention:

  • Attacks of migraine;
  • Kinetosis (sea and air sickness).

Contraindications

  • syndrome of glucose-galactose malabsorption, galactose intolerance, lactase deficiency;
  • period of pregnancy and breastfeeding;
  • age up to 5 years;
  • individual intolerance of the drug components.

According to the instructions, Stugeron should be administered with caution to patients with Parkinson's disease.

Intended use for pregnancy and lactation

There is no information on the safety of the drug for a pregnant woman and fetus. Therefore, the use of the drug to treat women during pregnancy is justified only if the threat to the health of the mother exceeds the potential risk to the fetus.

For the time of Stugeron's application, stop lactation.

Dosage and route of administration

As indicated in the instructions for use Stugeron should be taken orally after a meal.

Recommended single doses:

  • vestibular disorders - 25 mg;
  • disorders of the blood circulation of the brain - 25-50 mg;
  • violations of peripheral circulation - 50-75 mg;

Frequency of admission - 3 times a day.

Patients with hypersensitivity to begin treatment is recommended with ½ dose, gradually increasing it.

The duration of treatment, depending on the indications, can range from several weeks to several months.

With kinetosis, the drug should be taken 30 minutes before the trip: adults - 25 mg (if necessary, at the same dose can be repeated after 6 hours), children - 12.5 mg.

Side effect

Receiving tablets Stugeron can cause the development of negative pathological reactions from various organs and systems:

  • digestive system: pain in the epigastric region, dry mouth, cholestatic jaundice, dyspepsia;
  • dermatological reactions: skin rash, sweating, development of lupus-like syndrome; extremely rarely - lichen planus;
  • central nervous system: headache, fatigue, drowsiness, depression, extrapyramidal disorders (increase muscular tonus, tremor of extremities, hypokinesia in elderly patients with prolonged therapy, requiring withdrawal of treatment);
  • Other: weight gain, allergic reactions.

Overdose

The maximum recommended dose of Stugeron should not be more than 9 tablets (225 mg) per day.

In case of overdose symptoms, the stomach should be washed and activated charcoal, since the specific antidote to cinnarizine is unknown. Symptomatic therapy is also recommended.

special instructions

With prolonged use, it is recommended that a check examination of liver function, kidney function, and peripheral blood picture is recommended.

At the beginning of treatment should be refrained from potentially dangerous activities that require increased concentration of attention and psychomotor reactions, as well as from drinking alcohol.

In connection with the presence of antihistamine effect, Stugeron can influence the result of anti-doping control of athletes (false positive result), and also can neutralize positive reactions during skin diagnostic tests (for 4 days before the study treatment should be canceled).

Patients suffering from Parkinson's disease should be prescribed Stugeron only when the intended benefit exceeds the potential risk of deterioration.

Interaction with other drugs

Strengthens the effect of alcohol and sedatives.

With simultaneous application with nootropic, antihypertensive and vasodilating agents, enhances their effect, and with simultaneous use with drugs prescribed for arterial hypotension - reduces their effect.

Reviews

We offer you to read reviews of people who used the drug Stugeron:

  1. Tatyana. And it helps me a lot. The first 2-3 days sleepiness was terrible, but now it's better and calmer, and at night I sleep. I drink for a month, spring and autumn. Excellent medicine.
  2. Ildar. If I knew that Stugeron was just ordinary Cinnarizine, I would never have bought it in the original packaging. Because of Cinnarizin's headache, so from Stugeron, she was sick no less. Apparently this medicine does not just go to me, but I wanted to get rid of dizziness and noise in my ears. With this in general trouble ...
  3. Zhenya. My daughter was 7 months old when the neurologist prescribed a squarer. We had problems with sleeping, a lot of overexcitability, nervousness. In general, the child was crying all the time. We took 1/2 tablet a month. The result was not any. Whether the neurologist has got to us unskilled, whether tablets stupid. Asked the girls on the forum, they say that they also did not see the result of taking these pills.

Analogues

Structural analogs for the active substance:

  • Vertizine;
  • Vertizin Forte;
  • Cinedal;
  • Cinnarizine;
  • Cinnaron;
  • Cinnasan.

Analogues on the pharmacological group (means for the treatment of cerebral atherosclerosis):

  • Agapurin;
  • Aminalon;
  • Antisclerin;
  • Vestibo;
  • Vinpoton;
  • Vinpocetine;
  • Gamalon;
  • Dimephosphone;
  • Zocor;
  • Zokor forte;
  • Instenon;
  • Cavinton;
  • Cavinton forte;
  • Combbitropyl;
  • Xantinol nicotinate;
  • Mexidol;
  • Memorial;
  • Neurox;
  • Nicergoline;
  • Nootebril;
  • Nootropil;
  • Omaron;
  • Pantogam;
  • Pentoxifylline;
  • Ralofect;
  • Sermion;
  • Simlo;
  • Trental;
  • Fezam;
  • Cytoflavin;
  • Eikonol;
  • Eifitol;
  • Esledin.

Before buying an analogue, consult your doctor.

Cavinton or Stugeron?

Both drugs are analogues, because both improve cerebral circulation. However, each drug has its own characteristics of action and therapeutic effects, and therefore to assess which of them is better or worse is simply impossible.

Vinpotropil and Stugeron - can I apply together?

Yes, Vinpotropil and Stugeron can be taken together, but this combination of drugs is not entirely justified. The fact is that Stugeron improves cerebral circulation. A Vinpotropil is a complex preparation containing vinpocetine and piracetam, as a result of which it simultaneously improves cerebral circulation and has a nootropic effect (improves memory, attention and productivity of thinking).

Therefore, taking Vinpotropil, you can simultaneously get the same effect as Stugeron, and additionally the action of a nootropic drug. Thus, it seems impractical to take Vinpotropil with Stugeron, since the effect of improving the cerebral circulation is available for both drugs and is actually duplicated.

Shelf life and storage conditions

Store at 15-30 ° C, in a dry place out of the reach of children.

Shelf life - 5 years.


How to choose probiotics for the intestine: a list of drugs.


Effective and inexpensive cough syrups for children and adults.


Modern non-steroidal anti-inflammatory drugs.


Review of tablets from the increased pressure of the new generation.

Antiviral drugs are inexpensive and effective.